Lu Lu

MiR-638 serves as a tumor suppressor by targeting HOXA9 in glioma.

Dahai Zheng, X. Wang, Lu Lu, 2018, European review for medical and pharmacological sciences.

MiR‐505 promotes M2 polarization in choroidal neovascularization model mice by targeting transmembrane protein 229B

Xian Wang, Q. Yuan, Su Zhao, 2019, Scandinavian journal of immunology.